Jump to content

Recommended Posts

Posted

Variations in a gene that influences the innate immune system—the part of the immune system that provides short-term protection against infection—may be associated with lung cancer survival.

Curtis Harris, M.D., of the National Cancer Institute in Bethesda, Md., and colleagues examined whether any of five variations of the MBL2 gene influenced survival among 558 white patients and 173 African-American patients with non–small-cell lung cancer.

Some gene variants were associated with improved survival among white patients, but not African-American patients. White patients who did not have the gene variants had poorer survival, particularly the heavy smokers.

“This study may provide insight into the continued disparity in lung cancer survival between African-American and white patients,” the authors write. Journal of the National Cancer Institute

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.